Cargando…
Repurposing Disulfiram (Tetraethylthiuram Disulfide) as a Potential Drug Candidate against Borrelia burgdorferi In Vitro and In Vivo
Lyme disease caused by the Borrelia burgdorferi (Bb or B. burgdorferi) is the most common vector-borne, multi-systemic disease in the USA. Although most Lyme disease patients can be cured with a course of the first line of antibiotic treatment, some patients are intolerant to currently available ant...
Autores principales: | Potula, Hari-Hara S. K., Shahryari, Jahanbanoo, Inayathullah, Mohammed, Malkovskiy, Andrey Victorovich, Kim, Kwang-Min, Rajadas, Jayakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557442/ https://www.ncbi.nlm.nih.gov/pubmed/32971817 http://dx.doi.org/10.3390/antibiotics9090633 |
Ejemplares similares
-
Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31
por: Pothineni, Venkata Raveendra, et al.
Publicado: (2020) -
Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases
por: Liegner, Kenneth B.
Publicado: (2019) -
Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening
por: Pothineni, Venkata Raveendra, et al.
Publicado: (2016) -
Borreliacidal activity of Borrelia metal transporter A (BmtA) binding small molecules by manganese transport inhibition
por: Wagh, Dhananjay, et al.
Publicado: (2015) -
PEG/Dextran Double Layer Influences Fe Ion Release and Colloidal Stability of Iron Oxide Nanoparticles
por: Mohammadi, M. Rezaa, et al.
Publicado: (2018)